Development of Thermoreversible Dental Gel with Berberine
https://doi.org/10.33380/2305-2066-2020-9-4-88-92
Abstract
Introduction. Dental gel is one of the modern dosage forms with optimal biopharmaceutical properties for the treatment and prevention of oral diseases An isoquinoline alkaloid berberine is the promising active substance with antibacterial and anti-inflammatory effect, capable of forming stable dispersed systems with gel-forming components. It is noteworthy that, despite the pronounced antimicrobial activity of the alkaloid berberine, there is currently no dental dosage form with this component on the pharmaceutical market, and therefore research in this direction is of great interest.
Aim. Selection of the optimal technology for obtaining dental gel with berberine for the treatment of oral diseases.
Materials and methods. Berberine bisulfate (manufactured by CJSC «Vifitech», Obolensk, Moscow region, RF), poloxamers P407 and P338 (EP, USP/N; BASF, Germany), propylene glycol (USP; BASF, Germany), sodium chloride (Sigma-Aldrich, Germany, Cat. No. S9888), mucin type II from a pig stomach (Sigma-Aldrich, Germany, Cat. No. M2378). In the development of the composition and technology for the preparation of gels, a magnetic stirrer with a temperature control function (C-MAG HS 7 from IKA, Germany) was used. Gels were prepared by the «hot method» and «cold method».
Results and discussion. The production of the gel by the «hot method» provided a uniform dosage form. The obtained pH value is within the range of optimal diapason. Measurement of the specific peel force of the model gel sample showed pronounced mucoadhesive properties, which indicates that there is no need to adjust this parameter by introducing additional components into the formulation. The spectroscopic method is applicable for the analysis of berberine gel. It has been found that a significant dilution of the reference substance sample is required to develop an identification procedure.
Conclusion. The production of a sample of the dosage form by the «hot method» is optimal, which is probably due to the effect of solubilization and better distribution of the active substance in the base.
About the Authors
A. G. PalvinskiyRussian Federation
Artemiy G. Palvinskiy
Department of Pharmaceutical Technology
21, 5-ya Parkovaya str., Moscow, 105043
E. O. Bakhrushina
Russian Federation
Elena O. Bakhrushina
Department of Pharmaceutical Technology
21, 5-ya Parkovaya str., Moscow, 105043
Z. M. Kozlova
Russian Federation
Zhanna M. Kozlova
Department of Pharmaceutical Technology
21, 5-ya Parkovaya str., Moscow, 105043
A. A. Sinitsyna
Russian Federation
Anastasiia A. Sinitsyna
Department of Pharmacy
1/17, Skladochnaya str., Moscow, 125018
I. I. Krasnyuk
Russian Federation
Ivan I. Krasnyuk
Department of Pharmaceutical Technology
21, 5-ya Parkovaya str., Moscow, 105043
References
1. Rolik S. N., Pechenezhskaia L. A., Baglyk T. V., Sokolova I. I., German S. I. Development and research of dental gel. Ukrains'kij stomatologіchnij al'manah. 2011;3:58–60. (In Ukraine).
2. Nazir M. A. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72–80.
3. Kopetskiy I. S., Pobozhieva L. V., Sheveluk Yu. V. Correlation between Periodontitis and Systemic Diseases. Lechebnoye delo. 2019;2:7–12. (In Russ.). DOI: 10.24411/2071-5315-2019-12106.
4. Kachesova E. S., Shevchenko E. A., Uspenskaya O. A. A New Regimen of Complex Therapy for Aggressive Periodontitis. Sovremennye tekhnologii v medicine = Modern Technologies in Medicine. 2017;9(4):209– 216. (In Russ.). DOI: 10.17691/stm2017.9.4.26.
5. Sampiev A. M., Bespalova A. V., Nikiforova E. B. Biopharmaceutical Study To Identify The Optimal Composition Dental Gel With Trimekain. Zhurnal nauchnyh statej Zdorov'e i obrazovanie v XXI veke = The journal of scientific articles Health & Education in millennium. 2016;18(9):107–111. (In Russ.).
6. Chu M., Xiao R.-Х., Yin Y.-N., Wang X., Chu Z.-Y., Zhang M.-B., Ding R., Wang Y.-D. Berberine: A Medicinal Compound for the Treatment of Bacterial Infections. Clinical Microbiology: Open Access. 2014;3(3): 132–158. DOI: 10.4172/2327-5073.1000150.
7. Anurova M. N., Bakhrushina E. O., Barnolitskiy G. G., Krechetov S. P. Justification of the rheological optimum in the development of semisolid forms. Dental gels. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2017;2(19):124–128. (In Russ.).
8. Bakhrushina E. O., Nikiforova D. A., Demina N. B. The main aspects of the thermorreversible polycomplexes of poloxamers developing. Zhurnal nauchnyh statej Zdorov'e i obrazovanie v XXI veke = The journal of scientific articles Health & Education in millennium. 2018;20(5):103–106. (In Russ.).
9. Ediriweera D. S., Dilina N., Saparamadu V., Fernando I., Kurukulasuriya B., Fernando D., Kurera J. Aspirin is associated with low oral pH levels and antacid helps to increase oral pH. BMC Res Notes. 2018;11(1):137. DOI: 10.1186/s13104-018-3247-3.
Review
For citations:
Palvinskiy A.G., Bakhrushina E.O., Kozlova Z.M., Sinitsyna A.A., Krasnyuk I.I. Development of Thermoreversible Dental Gel with Berberine. Drug development & registration. 2020;9(4):88-92. (In Russ.) https://doi.org/10.33380/2305-2066-2020-9-4-88-92